Latest News about ILMN
Recent news which mentions ILMN
The Week Ahead In Biotech (Feb. 6-12): Pfizer, AstraZeneca Earnings, Conference Presentations, IPOs And More
February 06, 2022
From Benzinga
From MarketWatch
3 Growth ETFs to Consider Buying During This Correction
January 29, 2022
From Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
January 26, 2022
From Benzinga
Buy Smart With Software Stocks on the Dip
January 24, 2022
From InvestorPlace
What's the Outlook for Illumina?
January 23, 2022
From Motley Fool
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 18, 2022
January 18, 2022
From Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
January 12, 2022
From Benzinga
If You Invested $1,000 When Illumina Acquired Solexa, Here's How Much You'd Have Now
January 12, 2022
From Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 12, 2022
January 12, 2022
From Benzinga
48 Biggest Movers From Yesterday
January 12, 2022
From Benzinga
These 2 Nasdaq Winners Are Lighting Up the Market Tuesday
January 11, 2022
From Motley Fool
30 Stocks Moving In Tuesday's Mid-Day Session
January 11, 2022
From Benzinga
$100 Invested In This Stock 5 Years Ago, Would Be Worth This Much
January 11, 2022
Tickers
ILMN
From Benzinga
From Benzinga
10 Biggest Price Target Changes For Tuesday
January 11, 2022
From Benzinga
21 Stocks Moving in Tuesday's Pre-Market Session
January 11, 2022
From Benzinga
A Peek Into The Markets: US Stock Futures Higher Ahead Of Powell
January 11, 2022
From Benzinga
5 Stocks To Watch For January 11, 2022
January 11, 2022
From Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
January 10, 2022
From Benzinga
"Motley Fool Money" 2022 Investing Preview
January 07, 2022
From Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For January 7, 2022
January 07, 2022
From Benzinga
Why Jim Cramer Likes Illumina And Enterprise Products Partners
January 06, 2022
From Benzinga
The Daily Biotech Pulse: Lilly Strikes Neurological R&D Collaboration, Valneva Confirms Vaccine Timelines, Biohaven Gains On Strong Migraine Drug Sales
January 06, 2022
From Benzinga
10 Health Care Stocks Whale Activity In Today's Session
January 03, 2022
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.